Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results
- PMID: 15838014
- DOI: 10.1200/JCO.2005.05.332
Cardiotoxicity of epirubicin versus doxorubicin: cost and clinical results
Comment on
-
Long-term cardiac follow-up in relapse-free patients after six courses of fluorouracil, epirubicin, and cyclophosphamide, with either 50 or 100 mg of epirubicin, as adjuvant therapy for node-positive breast cancer: French adjuvant study group.J Clin Oncol. 2004 Aug 1;22(15):3070-9. doi: 10.1200/JCO.2004.03.098. J Clin Oncol. 2004. PMID: 15284257 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
